- Study at Deakin
- Life at Deakin
- Industry and community
- About Deakin
Note: The 2012, 2013, 2014, 2015 publications have not been audited.
Giovanni Scapagnini may be from another institution or only recently joined Deakin University.
Maes, Michael*, Fisar, Zdenek*, Medina, Miguel*, Scapagnini, Giovanni*, Nowak, Gabriel* and Berk, Michael* (2012) New drug targets in depression : inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors, Inflammopharmacology, vol. 20, no. 3, pp. 127-150, Birkhaeuser Verlag AG, Basel, Switzerland [C1.1]
ERA journal ID: 14771 – Scopus EID: 2-s2.0-84862769027
Citation counts: Scopus - 63
DRO entry for this publication
No grants and/or consultancies found or audited – the 2014 HERDC financial return has not been completed or loaded as yet.
No completions found or audited.
DRO to publications collection last synchronised: Thursday 29th January 2015 10:04pm